Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-propanesulfonic Acid, 3-((2-amino-3-methyl-1-oxobutyl)amino)-
2. 3-(l-valyl) Amino-1-propanesulfonic Acid
3. 3-(valylamino)-1-propanesulfonic Acid
4. Alz-801
1. Alz-801
2. 1034190-08-3
3. Blu8499
4. Nrm8499
5. Blu-8499
6. Nrm-8499
7. (s)-3-(2-amino-3-methylbutanamido)propane-1-sulfonic Acid
8. Valiltramiprosate [usan]
9. Ghg2b47067
10. 3-[(2s)-2-amino-3-methylbutanamido]propane-1-sulfonic Acid
11. Valiltramiprosate
12. Unii-ghg2b47067
13. Valiltramiprosate [inn]
14. Chembl4650301
15. Schembl13944044
16. Who 11912
17. 3-(valylamino)-1-propanesulfonic Acid
18. Hy-117259
19. Cs-0064594
20. 1-propanesulfonic Acid, 3-((2-amino-3-methyl-1-oxobutyl)amino)-
21. 3-((2s)-2-amino-3-methylbutamido)propane-1-sulfonic Acid
22. 3-[[(2s)-2-amino-3-methylbutanoyl]amino]propane-1-sulfonic Acid
| Molecular Weight | 238.31 g/mol |
|---|---|
| Molecular Formula | C8H18N2O4S |
| XLogP3 | -3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 238.09872823 g/mol |
| Monoisotopic Mass | 238.09872823 g/mol |
| Topological Polar Surface Area | 118 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 294 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
31
PharmaCompass offers a list of Valiltramiprosate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Valiltramiprosate manufacturer or Valiltramiprosate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valiltramiprosate manufacturer or Valiltramiprosate supplier.
PharmaCompass also assists you with knowing the Valiltramiprosate API Price utilized in the formulation of products. Valiltramiprosate API Price is not always fixed or binding as the Valiltramiprosate Price is obtained through a variety of data sources. The Valiltramiprosate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Valiltramiprosate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valiltramiprosate, including repackagers and relabelers. The FDA regulates Valiltramiprosate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valiltramiprosate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Valiltramiprosate supplier is an individual or a company that provides Valiltramiprosate active pharmaceutical ingredient (API) or Valiltramiprosate finished formulations upon request. The Valiltramiprosate suppliers may include Valiltramiprosate API manufacturers, exporters, distributors and traders.
Valiltramiprosate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Valiltramiprosate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Valiltramiprosate GMP manufacturer or Valiltramiprosate GMP API supplier for your needs.
A Valiltramiprosate CoA (Certificate of Analysis) is a formal document that attests to Valiltramiprosate's compliance with Valiltramiprosate specifications and serves as a tool for batch-level quality control.
Valiltramiprosate CoA mostly includes findings from lab analyses of a specific batch. For each Valiltramiprosate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Valiltramiprosate may be tested according to a variety of international standards, such as European Pharmacopoeia (Valiltramiprosate EP), Valiltramiprosate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Valiltramiprosate USP).
